Guerbet

Guerbet Logo
P.O. Box 50400
214 Carnegie Center Suite 300 Princeton, NJ 08540
eMail:
Website:
https://www.guerbet-us.com
Phone:+33 1 45 91 5037
Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide. It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to help providers improve the diagnosis and treatment of patients. From adapting to MACRA requirements and Joint Commission recommendations, to informing radiologists with deep patient insights, discover how our Digital Solutions can help you stay a step ahead.
Latest from Guerbet
Digital X-Ray
Guerbet to sell its urological imaging business to Del Medical
By AuntMinnie.com staff writers
Guerbet will sell its urological imaging business to Del Medical, according to a deal announced July 23.
July 24, 2024
The Hydra Vision DR system. Image courtesy of Guerbet
MRI
French-led team unveils 11.7 tesla MRI scans of human brain
By Philip Ward
A research group based in Saclay, near Paris, has taken the wraps off what it claims are the world's first MRI scans of the human brain in vivo taken at a field strength of 11.7 tesla. President Macron has congratulated the researchers.
April 4, 2024
2024 04 03 Brain Scan At 11 7 Tesla
MRI
Use CAD to assess breast tissue volume on MRI
By Kate Madden Yee
Using CAD software to assess enhancing breast tissue as a percentage of the entire breast volume on contrast MR imaging could improve breast cancer diagnosis.
March 14, 2024
Mri Breast Cancer
Practice Management
IMV: Nonhospital sites see increased competition for oncology-related imaging
By Davin Korstjens
In 2023, nonhospital sites faced more competition compared to hospital-based facilities for oncology-related diagnostic imaging scans, according to IMV’s recent report.
January 16, 2024
Cancer Cell
Equipment
IMV: MR departments seek to leverage AI to improve workflow, productivity
By Davin Korstjens
In 2023, the top priorities for MR departments are to increase patient satisfaction and improve MRI department workflow and productivity.
December 27, 2023
Mri Machine Screens
MRI
Guerbet to highlight MRI contrast agent gadopiclenol at RSNA
By AuntMinnie.com staff writers
Guerbet plans to highlight its gadopiclenol contrast agent (Elucirem) for MRI at the upcoming RSNA meeting.
November 3, 2023
Guerbet Rsna 2019 400
Practice Management
IMV: Hospital-based procedures drive CT procedure volume growth
By Davin Korstjens
CT procedure volumes increased 9.1% from 2022 to 2023, according to IMV’s recently published 2023 CT Market Outlook Report, due in large part to hospital-based procedures.
November 3, 2023
Ct Scanner Bore
MRI
Guerbet, Applied Radiology introduce 'Elucirem' challenge
By AuntMinnie.com staff writers
Guerbet and Applied Radiology collaborating on a contest for MRI professionals called "Elucirem: The Reveal Image Challenge."
May 22, 2023
2020 02 03 22 07 3929 Trophy Award 400
Breast
CEM on par with breast MRI in lobular breast cancer staging
By Amerigo Allegretto
Contrast-enhanced mammography (CEM) may be an alternative to breast MRI for preoperative staging of invasive lobular carcinoma, suggests findings published May 13 in the European Journal of Radiology.
May 18, 2023
2019 04 15 22 17 2307 Breast Cancer 400
MRI
Guerbet's gadopiclenol agent classified as low risk
By AuntMinnie.com staff writers
Guerbet's Elucirem macrocyclic gadolinium-based contrast agent has been classified as a group II agent by the American College of Radiology.
May 9, 2023
2019 12 18 19 15 2524 Guerbet Rsna 2019 400
CT
IMV: CTA and LDCT procedures show five-year growth trend
By Davin Korstjens
Overall CT procedure volumes have decreased since 2018, but non-cardiac CT angiography (CTA) and low-dose CT (LDCT) for lung cancer screening have shown sustained growth over this period, according to IMV Medical Information Division.
April 10, 2023
2022 07 21 18 40 3375 Ct Scan Patient2 400
MRI
IMV: MR volumes down, but radiology departments remain positive
By Davin Korstjens
MRI procedure volumes are down from a peak in 2019, but radiology departments remain positive that volume will rebound, according to IMV's 2022 MR Market Outlook Report.
April 3, 2023
2020 08 14 16 38 7291 Mri Scanner2 400
MRI
U.S. sites begin trials of Bracco's Vueway contrast agent
By AuntMinnie.com staff writers
Contrast agent developer Bracco Diagnostics said that Wellstar Health System is among the first in the U.S. to begin trials of its Vueway (gadopiclenol) macrocyclic gadolinium-based contrast agent for MRI.
February 13, 2023
2020 10 16 23 20 7849 Bracco2 Rsna 2018 400
MRI
Guerbet releases contrast MRI injection
By AuntMinnie.com staff writers
Guerbet is releasing the first production batch of its Elucirem injection, a macrocyclic gadolinium-based contrast agent for use in contrast-enhanced MRI.
February 1, 2023
2020 02 06 22 25 0448 Contrast Injector 400
MRI
IMV: MR departments optimistic on procedure volume growth, purchasing
By Davin Korstjens
Three-quarters of MR sites in the U.S. anticipate that their 2022 procedure volume will be higher in 2022 than in 2021, according to IMV Medical Information Division's 2022 MR Market Outlook Report. And that growth will be achieved across all site types.
January 12, 2023
2020 08 14 16 38 7291 Mri Scanner2 400